Immunicum AB (publ) Announces Participation at Conferences in June IMMUN.ST
30 May 2017
Immunicum AB (publ) Announces Participation at Conferences in JuneImmunicum AB (publ; First North Premier: IMMU.ST) a biopharmaceutical companyadvancing a novel immuno-oncology treatment against a range of solid tumors,today announced that Carlos de Sousa, MD, CEO of Immunicum, has been invitedto present the Company at several upcoming conferences in June and to
participate on a panel titled "New Frontiers in Oncology". In addition, the Company will attend the 2017 BIO International Convention.
Sachs Associates 3rd Annual Immuno-Oncology BD&L and Investment Forum
Date: June 2, 2017
Presentation Time: 11:10 am Central Standard Time
Venue: Hyatt Centric Chicago Magnificent Mile Hotel, Chicago, Illinois